Seasonal adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational GEPAT-SMART study. Επικοινωνία Submitted by Δημήτρης Σπάχος on Παρ, 12/04/2020 - 20:57
